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Follicular helper T (Tfh) cells comprise an important
subset of helper T cells; however, their relationship
with other helper lineages is incompletely under-
stood. Herein, we showed interleukin-12 acting via
the transcription factor STAT4 induced both Il21
and Bcl6 genes, generating cells with features of
both Tfh and Th1 cells. However, STAT4 also induced
the transcription factor T-bet. With ChIP-seq, we
defined the genome-wide targets of T-bet and found
that it repressed Bcl6 and other markers of Tfh cells,
thereby attenuating the nascent Tfh cell-like pheno-
type in the late phase of Th1 cell specification. Tfh-
like cells were rapidly generated after Toxoplasma
gondii infection in mice, but T-bet constrained Tfh
cell expansion and consequent germinal center
formation and antibody production. Our data argue
that Tfh and Th1 cells share a transitional stage
through the signal mediated by STAT4, which pro-
motes both phenotypes. However, T-bet represses
Tfh cell functionalities, promoting full Th1 cell differ-
entiation.
INTRODUCTION
Differentiation of naive CD4+ T cells into functionally distinct T
helper subsets is essential for effective immunity toward diverse
microbial pathogens (Abbas et al., 1996; Murphy and Reiner,
2002). These subsets are specified by extrinsic and intrinsic
cues, and the resultant cell populations acquire seemingly stable
phenotypes that are reinforced by epigenetic modifications
(Ansel et al., 2003; Aune et al., 2009). The cytokine environment
during priming with consequent activation of signal transducer
and activator of transcription (STAT) family DNA binding proteins
are key initiators of this process. That is, the cytokines IL-12 and
IFN-g acting via STAT4 and STAT1 are important for specifica-
tion and cell fate commitment for T helper 1 (Th1) cells (Szabo
et al., 2003; Wilson et al., 2009). Activation of STAT1 andISTAT4 promote expression of Tbx21 (T-bet), a master regulator
that promotes Th1 cell differentiation (Afkarian et al., 2002;
Lighvani et al., 2001).
Follicular helper T (Tfh) cells have recently been proposed
to be another distinct subset of helper T cells with specialized
function in enhancing germinal center (GC) formation and regu-
lating B cell function (Crotty, 2011; Fazilleau et al., 2009; King
et al., 2008; Nurieva and Chung, 2010; Yu and Vinuesa, 2010).
Tfh cells are characterized by selective expression of a variety
of molecules including the surfacemarkers such as CXC chemo-
kine receptor 5 (CXCR5), programmed death 1 (PD-1), and
inducible costimulator (ICOS), and their signature cytokine has
been suggested to be IL-21 (Crotty, 2011). As with other line-
ages, extrinsic cytokine cues, namely IL-6 and IL-21, acting via
STAT3, have been proposed to be drivers of Tfh cell differentia-
tion (Fazilleau et al., 2009; King et al., 2008). These factors induce
expression of Bcl6, which has come to be viewed as the critical
regulator of Tfh cells (King et al., 2008; Nurieva et al., 2009). Bcl6,
in turn, promotes CXCR5 expression and GC formation while
functioning as a transcriptional repressor for alternative lineages
by suppressing cytokines, transcription factors, and microRNAs
essential for other cell fates (Johnston et al., 2009; Nurieva
et al., 2009; Yu et al., 2009). These findings have been invoked
to support the lineage sovereignty of Tfh cells.
However, there are other seemingly conflicting findings with
regard to the origin and generation of Tfh cell and their relation-
ship to other lineages. First, CXCR5+ Tfh cells are present in the
setting of STAT3 deficiency, suggesting alternative, STAT3-
independent pathways for Tfh cell development (Eddahri et al.,
2009). Recent results support this by demonstrating that IL-6
and IL-21 are insufficient for Tfh cell generation in vivo (Eto
et al., 2011; Poholek et al., 2010). Second, activated CD4+
T cells are not devoid of Bcl6 and IL-21; these factors are not
exclusively expressed by Tfh cells (Lund et al., 2005; Mehta
et al., 2005; Suto et al., 2008; Wei et al., 2007). Third, it has
been reported that IL-12 is capable of driving IL-21 production
in human T cells, with the generation of Tfh cell-like (Ma et al.,
2009; Schmitt et al., 2009), although it has also been reported
that IL-12 does not induce IL-21 production in murine T cells
and that T-bet negatively regulates IL-21 (Mehta et al., 2005;
Suto et al., 2008). CXCR5+CD4+ human memory T cells have
been reported to share functional properties with Tfh cells, butmmunity 35, 919–931, December 23, 2011 ª2011 Elsevier Inc. 919
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Opposing Roles of STAT4 and T-bet in Tfh-like Cellscomprise Th1, Th2, and Th17 cells. However, Th2 and Th17, but
not Th1, cells have the capacity to help B cells (Morita et al.,
2011). Thus, it remains to be determined whether there is
a species-specific difference in the regulation of IL-21. Fourth,
whether Tfh cells can become differentiated Th1, Th2, Th17,
and regulatory T (Treg) cells or vice versa is also unclear; how-
ever, Treg cells can differentiate into Tfh cells in Peyer’s patches
in the gut (Tsuji et al., 2009). These results raise several
important questions regarding the relationship between Tfh
and Th1 cells. Does STAT4 directly drive markers of Tfh cells in
mouse and man, and if so, how does this relate to the Th1 cell
differentiation program? Specifically, what are the respective
roles of STAT4 and T-bet on Tfh cell differentiation and the
induction of the master regulator, Bcl6, and what are the
molecular mechanisms that determine Tfh versus Th1 cell
specification?
In this study, we report that IL-12 can induce IL-21- and IFN-g-
producing cells, which share features of both Tfh and Th1 cells.
We found that STAT4 regulates multiple genes involved in Tfh
cell development. Early on, these cells expressed both Bcl6
and T-bet. However, Tfh cell-like features were not sustained
during later stage of Th1 cell differentiation because of ex-
pression of T-bet and IFN-g, which in concert antagonized
expression of Bcl6 and other Tfh cell genes and promote Th1
cell specification. Thus, the differentiation of Th1 cells represents
a dynamic balance of signals mediated by STAT4 and T-bet,
whose actions are distinct in terms of effects on Tfh versus
Th1 cell phenotype.
RESULTS
IL-12 Induces Genes that Contribute to Both
Tfh and Th1 Cell Phenotypes
To begin to understand the relationship between Th1 and Tfh
cells, we polarized naive CD4+ T cells under conditions known
to promote production of IL-21 versus standard Th1 cell condi-
tions. Although IL-6 generated cells that express IL-21 and
not IFN-g, IL-12 efficiently produced cells that express IFN-g.
However, a quarter of the cells induced by IL-12 produced
both IFN-g and IL-21 (Figure 1A). These results were confirmed
at the level of mRNA and by ELISA and by the kinetics of induc-
tion (Figures S1A–S1C available online).
We next sought to determine whether the cells generated in
response to IL-12 exhibited other Tfh cell-like features. We found
that IL-12 induced expression of phenotype-associated cell sur-
face molecules; in fact, the proportion of CXCR5+PD-1+ Tfh-like
cells and expression of ICOS were greater than when IL-6 was
used as a stimulus (Figures 1B and 1C). In addition, IL-12 and
IL-6 induced comparable expression of Bcl6 mRNA and protein
(Figures 1D and 1E).
Next, we compared the phenotypic differences between sub-
populations of Th1 cells that expressed high and low levels of
IL-21 or IFN-g. Surprisingly, IL-21+ cells also expressed signifi-
cantly higher amount of IFN-g, T-bet, CXCR5, PD-1, and ICOS
than did IL-21 cells (Figures 1F–1H). Likewise, IFN-g+ cells
expressed significantly higher levels of IL-21 and T-bet than
did IFN-g cells (Figure 1I). Thus, our data support the conten-
tion that IL-12 has the capacity to induce IL-21-producing cells
that exhibit fundamental features of both Th1 and Tfh cells.920 Immunity 35, 919–931, December 23, 2011 ª2011 Elsevier Inc.STAT4 Positively Regulates Genes that Contribute to
Both Tfh and Th1 Cell Phenotypes
IL-12 is known to activate STAT4, but it also activates other
STATs including STAT3 (Bacon et al., 1995). To compare the
contribution of STAT3 versus STAT4, we assessed IL-21 produc-
tion in the appropriate Stat-deficient cells. IL-6 effectively
induced IL-21, which was abrogated in Stat3-deficient (Stat3/)
cells (Figure 2A). IL-12-mediated IL-21 expression was also in-
hibited in Stat3/ cells; however, Stat4 deficiency abrogated
both IL-21 and IFN-g (Figure 2A). We considered the possibility
that once produced, IL-21 could act to further increase its
production via activation of STAT3 (Zeng et al., 2007) and dele-
tion of Stat3 would interrupt such an autocrine loop. In fact, we
found that IL-12-induced IL-21 production was partially inhibited
by blocking IL-21 (see below). Thus, we conclude that IL-12-
dependent activation of STAT4 directly promotes IL-21 produc-
tion, which in turn acts through STAT3 in a positive feedback
loop to maximize induction of IL-21.
We next evaluated the contribution of STAT4 on Tfh cell-
related genes and found that the proportion of CXCR5+PD-1+
cells and ICOS expression upregulated by IL-12 were markedly
decreased in Stat4/ cells (Figures 2B and 2C). Although IL-6-
mediated Bcl6 induction was markedly impaired, IL-12-depen-
dent upregulation of Bcl6 was not affected by STAT3 deficiency
(Figure 2D). In contrast, expression of Bcl6 by IL-12 was entirely
inhibited by STAT4 deficiency (Figure 2E). Thus, IL-12-depen-
dent Bcl6 expression is mediated by STAT4, not by STAT3.
To evaluate the relevance of these findings with respect to
in vivo humoral responses, we immunized wild-type and
Stat4/ mice with ovalbumin and assessed Tfh cell generation,
GC formation, and antibody production. We found that immu-
nized Stat4/ mice generated significantly fewer Tfh and GC
B cells and reduced amounts of IgG2b at day 4 postimmuni-
zation. However, no deficit was noted by day 8 (Figures
S2A–S2C). Although it is possible that the reduction in number
of GC B cells could be a consequence of intrinsic STAT4
deficiency in B cells themselves, the data indicated that
STAT4 contributes to early induction of Tfh cells. However,
the subsequent in vivo humoral response is normal, presumably
because STAT3 can compensate. Taken together, these find-
ings show that STAT4 positively regulates both Tfh and Th1
cell phenotypes.
Transient Nature of Tfh Cell-like Phenotype
during Th1 Cell Differentiation
We examined the time course of the relationship between Th1
and Tfh cell phenotypes. After the initiation of Th1 cell polariza-
tion, IL-21 induction closelymirrored that of IFN-g, at least during
the initial phase up to day 5; however, the proportion of IL-21-
producing cells declined thereafter (Figure 3A). This was not
the case for IFN-g-producing cells, the percentage of which
continued to increase over time. Similarly, both T-bet and Bcl6
were upregulated during the initial phase. However, Bcl6 expres-
sion gradually declined, whereas T-bet expression remained
elevated (Figure 3B). We evaluated whether the relative expres-
sion of T-bet and Bcl6 correlated with changes in phenotype at
day 5 of developing cells. We found that T-bet expression corre-
lated positively with IFN-g production, whereas Bcl6 negatively




Figure 1. IL-12 Induces Genes that Contribute to Tfh and Th1 Cell Phenotypes
Sorted naive CD4+ T cells were cultured under neutral, IL-12-, and IL-6-stimulated conditions for 5 days.
(A–C, F–I) FACS plots gated on CD4+ cells and percentage or mean MFI of CD4+ cells positive for intracellular IL-21, IFN-g, and T-bet (A, F, I) and cell surface
expression of CXCR5, PD-1 (B, G), and ICOS (C, H). Staining with an isotype control antibody was used to set gates (dotted lines).
(D) Relative mRNA expression of Bcl6 was evaluated by qPCR.
(E) Bcl6 and T-bet levels in whole cell lysates were analyzed by immunoblotting. A human Burkitt’s lymphoma cell line, Ramos, was used as a reference control.
(F–I) The percentages or MFI levels of the indicated markers gated on IL-21- or IFN-g-positive cells (red) are compared to that of IL-21- or IFN-g-negative cells
(blue) or CD4+ T cells cultured under neutral conditions (gray).
Representative data of three or more independent experiments are shown (mean ± SD). *p < 0.05, **p < 0.01. See also Figure S1.
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Opposing Roles of STAT4 and T-bet in Tfh-like Cellsboth T-bet and Bcl6 correlated positively with IL-21 production,
indicating differential modes of regulation of two cytokines. Bcl6
was necessary for CXCR5 expression and T-bet moderatelyIdownregulated its expression (Figure 3C). Collectively, a more
fully differentiated Th1 cell state is associated with the elevated
T-bet and eventual loss of Bcl6 expression.mmunity 35, 919–931, December 23, 2011 ª2011 Elsevier Inc. 921
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Figure 2. Induction of Tfh and Th1 Cell
Phenotypes by IL-12 Is Mediated by STAT4
Sorted naive CD4+ T cells from WT, Stat3/,
Stat4/, or Stat6/ mice were cultured under
neutral, IL-12, and IL-6 conditions for 5 days.
(A–C) Shown are flow cytometry plots gated on
CD4+ cells and percentage or mean MFI of CD4+
cells positive for expression of IL-21 and IFN-g (A),
CXCR5 and PD-1 (B), and ICOS (C).
(D and E) Levels of Bcl6, T-bet, phosho-STAT3,
total STAT3, phospho-STAT4, or total STAT4
in whole cell lysates were analyzed by
immunoblotting.
Representative data of three or more independent
experiments are shown (mean ± SD). *p < 0.05,
**p < 0.01. See also Figure S2.
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Opposing Roles of STAT4 and T-bet in Tfh-like CellsT-bet Negatively Regulates Tfh Cell-like Phenotype
in Th1 Cells
Previous work has indicated that T-bet negatively regulates
IL-21 (Mehta et al., 2005). We therefore compared wild-type
and T-bet-deficient (Tbx21/) cells for their cytokine production
after 5 days of in vitro Th1 cell polarization. Although the pro-
portion of IFN-g+ cells was reduced in Tbx21/ cells, as ex-
pected the proportion of IL-21+ cells was significantly increased
in Tbx21/ cells (Figure 4A).
We sought to determine whether T-bet repressed other Tfh
cell characteristics and found that in Tbx21/ cells, the propor-
tion of CXCR5+PD-1+ cells induced by IL-12 were enhanced
(Figure 4B), aswas the expression of Bcl6 (Figure 4C). To confirm
the apparent repressive effect of T-bet, we expressed T-bet by922 Immunity 35, 919–931, December 23, 2011 ª2011 Elsevier Inc.retroviral transduction in cells polarized
under Th1 cell conditions. As expected,
overexpression of T-bet enhanced IFN-g
production but suppressed IL-21 produc-
tion (Figures S3A–S3C). Importantly, we
also found that T-bet inhibited IL-12-
dependent Bcl6 induction (Figure 4D).
Of note, T-bet-dependent inhibition of
Bcl6 seemed not to be mediated via in-
duction of Blimp-1, an important re-
pressor for Bcl6 (Johnston et al., 2009),
because Blimp1 expression was not dif-
ferent in the presence or absence of
T-bet (Figures S3D and S3E). These
data argue that T-bet is necessary for
limiting other aspects of the Tfh cell
phenotype in Th1 cells.
Direct, Opposing Effects of STAT4
and T-bet on the Bcl6 Locus
To better understand how STAT4
and T-bet influence Tfh cell genes, we
employed genome-wide DNase hyper-
sensitivity (DHS) assay, along with
histone- and transcription factor-ChIP-
seq analysis. Consistent with previous
reports (Wei et al., 2010; Wilson et al.,
2009), we found that the Ifng locus con-tained multiple DHS peaks, STAT4 and T-bet binding sites, as
well as permissive H3K4me3 and H3K36me3 modifications in
wild-type Th1 cells (Figure 5A). These permissive histone marks
were absent in Stat4/ cells and reduced in Tbx21/ cells, sug-
gesting that both STAT4 and T-bet contributed to positively regu-
late transcription in the Ifng locus.
With respect to the Il21 locus, we found that the locus was
bound by STAT4 but not by T-bet (Figure 5B). Multiple DHS
peaks and permissivemarks were present in Th1 cell (Figure 5B),
with no repressive H3K27me3 marks (data not shown). Further-
more, permissive histone marks of Il21 locus were absent in
Stat4/ cells and increased in Tbx21/ cells (Figure 5B). Inter-
estingly, the Bcl6 locus exhibited an open and active chromatin
configuration, indicated by DHS peaks and permissive marks in
AB
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Figure 3. Transient Nature of Tfh Cell-like Phenotype during Th1Cell
Differentiation
Sorted naive CD4+ T cells were cultured under IL-12 conditions for up to
8 days. Cells were analyzed by flow cytometry for expression of IL-21 and
IFN-g (A, C), Bcl6 and T-bet (B, C), and CXCR5 (C) at the indicated days.
(A and B) Time course of IL-21, IFN-g, Bcl6, and T-bet expression. The figure
shows representative FACS plots gated on CD4+ cells (top) and percentage of
CD4+ cells positive for the indicated molecules (bottom).
Immunity
Opposing Roles of STAT4 and T-bet in Tfh-like Cells
ITh1 cell (Figure 5C), with no repressive H3K27me3 marks (data
not shown). H3K36me3 marks were lost in Stat4/ cells but
increased in Tbx21/ cells compared to the wild-type cells
(Figure 5C). These changes in chromatin configuration were
functionally relevant as shown by the fact that they are correlated
with changes in both the Il21 and Bcl6 gene expression (Figures
5D and 5E).
Of note, the Bcl6 locus was accessible in naive CD4+ T cells
and H3K4me3 marks were consistently present in all genetic
backgrounds of Th1 cells (Figure 5C). The consistent presence
of DHS and H3K4me3 around the Bcl6 locus suggests that
although Bcl6 expression can vary with different states of differ-
entiation, this locus remains poised for transcription even in the
absence of active transcription, consistent with a flexible view of
the Tfh cell phenotype (Lu et al., 2011).
The finding that T-bet negatively regulated Bcl6 expression
suggested to us that induction of T-bet in developing Th1 cells
should eventually contribute to the loss of Tfh cell characteristics
over time. As shown in Figure 5F, expression of Bcl6wasminimal
in naive CD4+ T cells but was induced by day 3 of in vitro Th1 cell
polarization to levels comparable to those found in isolated GCB
cells and Tfh cells (Figures 5F and S4A–S4D). Bcl6 was induced
in Stat4/ cells at early time points (day 3), because TCR and
costimulatory signals contribute to Bcl6 induction (Figures 5F
and S4C). However, Bcl6 levels were not sustained in Stat4/
cells, but were maintained in Tbx21/ cells for up to 8 days
(Figure 5F). Consistent with previous work (Nurieva et al., 2009;
Yu et al., 2009), overexpression of Bcl6 suppressed both IFN-g
and T-bet expression in Th1 cells (Figures S4E–S4G). We also
found that in Th1 cells, both STAT4 and T-bet bound the
Cxcr5, Pdcd1, and Icos genes, and the chromatin structure
of these genes was in an open configuration (data not shown).
H3K4me3 marks around Cxcr5 locus were increased in
Tbx21/ cells, supporting the direct repression by T-bet (data
not shown). By contrast, there was little change in histone marks
of the Pdcd1 and Icos loci regardless of the genetic background,
suggesting indirect effects of T-bet on these genes. Functionally,
we found that the proportion of CXCR5+PD-1+ cells in devel-
oping Th1 cells was regulated in parallel with IL-21 expression.
The proportions increased initially but declined with the pres-
ence of T-bet (Figure 5F). Thus, T-bet represses multiple Tfh
cell-defining genes during later course of Th1 cell differentiation.
IL-12-Induced IFN-g Suppresses Tfh Cell Phenotype
Because both IFN-g and IL-21 were simultaneously produced in
Th1 cell, we investigated the influence of these cytokines on Th1
and Tfh cell phenotypes. To address this, we cultured naive
CD4+ T cells under Th1 cell-inducing conditions with exogenous
cytokines or neutralizing antibody.We observed that the effect of
IFN-g on cytokine production varied at different time points
during Th1 cell-inducing culture. At day 3, both IFN-g and
IL-21 production were increased by addition of excess exoge-
nous IFN-g and decreased by addition of neutralizing anti-
IFN-g (Figure 6A), arguing that IFN-g can be a positive regulator(C) Cells were gated based on T-bet and Bcl6 expression, and expression of
IFN-g, IL-21, and CXCR5 at day 5 in developing Th1 cells were compared.
Representative data from one of three independent experiments are shown
(mean ± SD).
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Figure 4. T-bet Represses Tfh Cell-like Phenotype in Th1 Cells
(A–C) Sorted naive CD4+ T cells fromWT or Tbx21/mice were cultured under neutral or IL-12 conditions for 5 days. Shown are FACS plots gated on CD4+ cells
and percentage of CD4+ cells positive for expression of IL-21 and IFN-g (A), CXCR5 and PD-1 (B), and Bcl6 and T-bet (C). Levels of Bcl6 and T-bet in whole cell
lysates were also analyzed by immunoblotting (C).
(D) Sorted naive CD4+ T cells from Tbx21/mice were infected with either control retrovirus (mock-GRV) or T-bet-expressing retrovirus (T-bet-GRV) for 3 days.
GFP+ cells were sorted by FACS and lysed for immunoblotting to evaluate Bcl6 and T-bet expression. Shown are FACS plots gated on GFP+CD4+ cells and
percentage of GFP+CD4+ T cells positive for expression of Bcl6 and T-bet.
Representative data of three or more experiments are shown (mean ± SD). *p < 0.05, **p < 0.01. See also Figure S3.
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time points, IL-21 production was significantly decreased by
exogenous IFN-g and increased by anti-IFN-g (Figure 6A). To
reconcile the seemingly contradictory effects of IFN-g, we as-
sessed IL-21 production in the Ifng-deficient cells and found
that at early time points, IL-12-induced IL-21 production was
reduced when Ifng was absent (Figure S5A). However, later on
IFN-g had the opposite effect on IL-21, Bcl6, andCXCR5 expres-
sion (Figures 6A and S5A–S5C). Thus, there seems to be a
biphasic effect of IFN-g on IL-21 production. The proportion of
CXCR5+PD-1+ cells was significantly decreased by exogenous
IFN-gand increasedbyanti-IFN-g at both timepoints (Figure 6B).
Moreover, Bcl6 expression was suppressed and T-bet expres-
sion was increased by exogenous IFN-g, whereas the opposite
was the case by inclusion of anti-IFN-g (Figure 6C). These effects
can be attributed to induction of T-bet, as evidenced by the lack
of effect in Tbx21/mice (data not shown; Lighvani et al., 2001).
The effects of modulating IL-21 were assessed at day 5 with
exogenous IL-21 or neutralizing sIL-21R-Fc. IL-21 production
was significantly increased by addition of exogenous IL-21 but
decreased by addition of neutralizing sIL-21R-Fc (Figure 6D).
Conversely, IFN-g production was decreased by exogenous924 Immunity 35, 919–931, December 23, 2011 ª2011 Elsevier Inc.IL-21 and increased by sIL-21R-Fc (Figure 6D), consistent with
previous data (Suto et al., 2006). The proportion of CXCR5+
PD-1+ cells, although not significant, showed a tendency to be
increased by IL-21 and decreased by sIL-21R-Fc (Figure 6E).
Bcl6 expression was increased and T-bet was decreased by
exogenous IL-21, whereas the opposite was the case by sIL-
21R-Fc (Figure 6F). These data suggest that IL-21 and IL-12
work in conjunction to enhance IL-21 and Bcl6 but work in oppo-
sition in regulating IFN-g and T-bet. Thus, IFN-g and IL-21 mimic
the effects of T-bet and Bcl6 in antagonizing each other’s
actions, despite being expressed simultaneously in developing
Th1 cells. This suggests that early on, the Tfh-Th1 cell phenotype
is quite plastic and can respond dynamically to intrinsic and
extrinsic factors.
T-bet Negatively Regulates Tfh Cell-Related
Functionalities of CD4+ T Cells during Infection
with T. gondii
To determine whether our in vitro findings could be recapitulated
in an in vivo situation, we analyzed mice infected with T. gondii,
an obligate intracellular parasite known to induce a strong




Figure 5. Opposing Effects of STAT4 and T-bet on Epigenetic Profiles of Tfh Cell Genes in Th1 Cells
Sorted naive CD4+ T cells from WT, Stat4/, or Tbx21/ mice were cultured under Th1 cell conditions.
(A–E) Cells were restimulated with anti-CD3 and anti-CD28 and IL-12 for 2 hr.
(A–C) DNase-seq and ChIP-seq were performed with naive CD4+ T cells and Th1 cells polarized for 7 days to map DHS, histone epigenetic marks, and binding of
STAT4 and T-bet. The genome browser view of Ifng (chr10: 117,865,988-117,895,063, DHS y axis: 0-3, H3K4me3 y axis: 0-8, H3K36me3 y axis: 0-3, binding of
STAT4 and T-bet y axis: 0-300), Il21 (chr3: 37,091,490-37,164,309, DHS y axis: 0-2, H3K4me3 y axis: 0-4, H3K36me3 y axis: 0-2, binding of STAT4 and T-bet
y axis: 0-150), andBcl6 (chr16: 23,951,786-24,014,614, DHS y axis: 0-3, H3K4me3 y axis: 0-6, H3K36me3 y axis: 0-2, binding of STAT4 and T-bet y axis: 0-60) loci
are shown. y axis shows the normalized tag number which is the tag count per one million of total tag count (tag-per-million).
(D and E) Relative mRNA expression of Il21 or Bcl6 at day 5 was compared in cells from WT (black) or Tbx21/ (green) mice.
(F) FACS analysis for IL-21, IFN-g, Bcl6, T-bet, CXCR5, and PD-1 gated on CD4+ cells were performed at day 0, 3, 5, and 8.
Representative data of two or more independent experiments are shown (mean ± SD). See also Figure S4.
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generated 7 days after infection and the vast majority of IL-21+
cells also expressed IFN-g and T-bet (Figures 7A–7C). The
proportions of IL-21+IFN-g and CXCR5+PD-1+ cells and Bcl6
levels were further increased in Tbx21/ mice (Figures
7A–7C). To assess the T cell-intrinsic requirement for T-bet in
the course of generating transitional Tfh-Th1 cells, we adoptivelyItransferred naive CD4+ T cells from wild-type and Tbx21/ into
Rag2 / mice and infected the recipients with T. gondii (Fig-
ure 7D). Wild-type and Tbx21/ cells expanded equally in
response to T. gondii up to day 15 (data not shown). However,
we found that the Tfh cell phenotype, as evidenced by expres-
sion IL-21, Bcl6, and CXCR5, was more prominent in Tbx21/





Figure 6. Effect of Modulating the Levels of IFN-g and IL-21 during the Course of In Vitro Th1 Cell Differentiation
Sorted naive CD4+ T cells were cultured under IL-12 conditions for 3–5 days. Combinations of IFN-g, IFN-g antibody, IL-21, or soluble IL-21 receptor-Fc
were added as indicated to enhance or deplete the levels of IFN-g or IL-21 in the culture.
(A, B, D, and E) Levels of IL-21 and IFN-g (A, D) and CXCR5 and PD-1 (B, E) on CD4+ cells were determined by FACS at day 3 and/or 5.
(C and F) Levels of Bcl6 and T-bet on CD4+ cells were determined by FACS and by immunoblotting at day 5.
Representative data of three independent experiments are shown (mean ± SD). *p < 0.05, **p < 0.01. See also Figure S5.
Immunity
Opposing Roles of STAT4 and T-bet in Tfh-like Cells
926 Immunity 35, 919–931, December 23, 2011 ª2011 Elsevier Inc.
Immunity
Opposing Roles of STAT4 and T-bet in Tfh-like Cells(Figures 7E–7H). These data show the coemergence of IL-21-
and IFN-g-producing cells, both as single-positive and double-
positive cells, 7 days postinfection. However, the proportion of
double-positive cells declined at day 15 in wild-type and
Tbx21/ cells. In contrast, IFN-g single-positive cells were in-
creased in wild-type cells whereas IL-21 single-positive cells
were increased in Tbx21/ cells (Figure 7F). By day 15, there
was reduction in expression of Bcl6 and the proportions of
CXCR5+PD-1+ cells in wild-type population whereas Tfh cell
markers were sustained in Tbx21/ population for up to
15 days (Figures 7E, 7G, and 7H). Collectively, the data indicate
that T cell-intrinsic T-bet deficiency allows expansion of Tfh-like
cells during Th1 cell responses.
We next sought to assess whether the observed expansion of
Tfh-like cells in Tbx21/ mice enhanced humoral responses.
Because of the early lethality associated with T. gondii infection
of Tbx21/ mice, we were unable to measure B cell responses.
As an alternative strategy, we compared production of anti-
body against soluble T. gondii antigen (STAg) in wild-type and
Tbx21/ mice. At 20 days postimmunization, GC formation
and antibody production were remarkably enhanced in Tbx21/
mice, highlighting the physiological relevance of T-bet in regu-
lating Tfh cell-mediated humoral responses (Figures 7I and 7J).
Thus, the emergent Tfh cell phenotype is constrained by the
induction of T-bet as cells become bona fide Th1 cells.
DISCUSSION
The extent to which Tfh and other CD4+ T cell subsets represent
distinct lineages that express lineage-defining master regulators
is subject of intense ongoing research (Murphy and Stockinger,
2010; O’Shea and Paul, 2010). The present data demonstrate
a previously unappreciated degree of phenotypic overlap
between Tfh and Th1 cells and illustrate molecular interplay
among ‘‘master’’ transcription factors such that dynamically
regulated expression of T-bet and Bcl6 affect STAT4-mediated
gene expression and ultimately define cellular phenotype.
Previous work has suggested that a species-specific effect of
IL-12 inducing IL-21 and other features of Tfh cells in human but
not mouse cells (Ma et al., 2009; Mehta et al., 2005; Schmitt
et al., 2009; Suto et al., 2008). However, recent work has shown
that murine Th1 cells can express IL-21 (Eto et al., 2011) and our
results indicate that IL-12 also has the capacity to induce
Bcl6 and Tfh cell surface markers. With this regard, temporal
considerations, rather than species difference, may provide
an explanation for the apparent discrepancy. In previous stud-
ies, cytokine production was measured in cells polarized for
5–7 days, times at which the Tfh cell-like phenotype of Th1 cells
has begun to wane. In addition, we used greater IL-12 concen-
trations than others; however, we do not believe that our results
are due to artificially high amounts of IL-12. Our results were
confirmed in vivo in a model associated with vigorous IL-12
production and intense Th1 cell responses induced by T. gondii.
The present study also provides the evidence to explain why
others have found STAT3 not to be essential for Tfh cell differen-
tiation (Eddahri et al., 2009; Schmitt et al., 2009). IL-12 acting via
STAT4 can be an early inducer of Tfh cell phenotype. Consistent
with redundant functions of STAT3 and STAT4 is recent work
which demonstrates that neither IL-6 nor IL-21 alone areIrequired for induction of Bcl6+ Tfh cells in vivo and in vitro (Eto
et al., 2011; Poholek et al., 2010). STAT4 appears to provide
an alternative mechanism, as our data argue that STAT3 and
STAT4 redundantly serve to induce IL-21, Bcl6, and other Tfh
cell molecules; both STAT4 and STAT3 directly bind these genes
and promote gene expression (Durant et al., 2010; Schmitt et al.,
2009; Wei et al., 2007, 2010). What differs between STAT3 and
STAT4 is the capacity to efficiently induce Tbx21 gene. It is
notable in this regard that IFN-g acting via STAT1 is also a potent
inducer of T-bet (Lighvani et al., 2001). However, unlike IL-12-
STAT4, IFN-g-STAT1 inhibits Bcl6 expression.
Although Tfh cells are a functionally critical subset of helper
T cells, it remains an open question whether Tfh cells are truly
a distinct lineage parallel to other subsets or rather represent
a temporary ‘‘state’’ of differentiation. As described in this
manuscript, during the course of Th1 cell differentiation, we
noted the appearance of IL-12-induced IL-21+IFN-g+Bcl6+T-
bet+ Tfh-Th1-like cells, which were followed by the generation
of fully differentiated IL-21IFN-g+Bcl6T-bet+ Th1 cells. Our
ChIP-seq findings do indicate that T-bet directly binds to Bcl6
locus and multiple other Tfh cell-related genes. The present
data confirm that both STAT4 and T-bet are indispensable posi-
tive regulators for full induction of IFN-g. Although STAT4 can
promote Tfh cell-like features, induction of T-bet inhibits Tfh
cell genes and tips the balance toward amore Th1 cell-dominant
phenotype. Our data indicate that early on after IL-12 stimula-
tion, cells are uncommitted and complete differentiation reflects
the counter-regulatory effects of STAT4 and T-bet.
Previous work has shown that Bcl6 functions as a transcrip-
tional repressor for T-bet (Nurieva et al., 2009; Yu et al., 2009);
however, it also appears that T-bet can limit expression of
Bcl6. Our results indicate that expression of T-bet and Bcl6
antagonized each other’s function, as did IFN-g and IL-21. The
action of T-bet to suppress the generation of Tfh cells and
humoral responses were confirmed in vivo dominant Th1 cell
response by T. gondii. Thus, T-bet-mediated downregulation
of Bcl6 is required to become bona fide Th1 cells. Recent work
also shows that Bcl6 and T-bet cooperate and can reduce
IFN-g production during Th1 cell differentiation (Oestreich
et al., 2011). Our data indicate that T-bet does not counterregu-
late IL-21 or Bcl6 during initial phase of Th1 cell differentiation;
presumably there are threshold levels of T-bet and Bcl6
expression that need to be reached, which subsequently dictate
the outcome of repression of Tfh or Th1 cell phenotypes. Inter-
estingly, there seems to be a biphasic effect of IFN-g: early on
it promotes IL-21 but later it inhibits. This finding may also be
a contributor to the seemingly contradictory effects of Bcl6
and T-bet.
Although Bcl6 has been argued to be the ‘‘master regulator’’
transcription factor for Tfh cells (King et al., 2008; Nurieva
et al., 2009), our data put this factor in a somewhat different light.
We noted that the Bcl6 locus is accessible in naive CD4+ T cells,
a finding that is consistent with our data and the data of others
indicating that Bcl6 is readily inducible by TCR stimulation alone
and further induced by STAT4 or STAT3 (Durant et al., 2010;
Lund et al., 2005; Ma et al., 2009; Nurieva et al., 2009; Schmitt
et al., 2009). Equally interesting is the fact that the Bcl6 locus is
not repressed in fully polarized Th1 cells. The accessibility, as-






Figure 7. T-bet Negatively Regulates Tfh Cell-Related Functionalities of CD4+ T Cells during Infection with T. gondii
(A–C) WT or Tbx21/ mice were infected with 20 cysts of the avirulent T. gondii strain ME49. Splenocytes were analyzed by FACS 7 days after infection
for expression of IL-21, IFN-g, and T-bet (A) gated on CD4+ cells, and CXCR5 and PD-1 gated on CD4+CD44+ cells (B). Data indicate mean ± SD from at
least four mice per group in two separate infections. Bcl6 and T-bet levels in whole cell lysates from sorted CD4+ cells were determined by
immunoblotting (C).
(D–H) Rag2 / mice were reconstituted with 1:1 mixture of WT (CD45.1+) and Tbx21/ (CD45.2+) naive CD4+ T cells. 7 days later, mice were infected with
T. gondii and followed for 7–15 days (D). Expression of IL-21 and IFN-g (E, F), Bcl6 and T-bet (E, G), and CXCR5 and PD-1 in CD4+CD44+ cells (E, H) was
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Collectively, these results argue that it may not be appropriate to
view Bcl6 simply as a master regulator of Tfh cells.
During the course of LCMV infection, it was noted that Tfh
cells maintained expression of IFN-g and T-bet; however, the
levels were low compared to typical Th1 cells (Johnston
et al., 2009). Other work showed that in chronic LCMV infection,
the induced Th1 cells ‘‘converted’’ to become Tfh cells later
during the immune response (Fahey et al., 2011). These data,
along with ours, suggest a model in which signals associated
with chronic antigenic exposure can sustain Bcl6 expression,
which overrides the inhibitory function of T-bet. Over time, limi-
tation of T-bet expression favors transition of nascent Th1 cells
to become Tfh cells. Conversely, signals that drive expression
of T-bet and limit Bcl6 expression favor ‘‘terminal differentia-
tion’’ of Th1 cells to become effector cells and limit Tfh cell
functionalities. Importantly, T-bet is not the only factor that
regulates Bcl6 expression. Previous work has demonstrated
that Bcl6 expression is not sustained in effector CD4+ T cells
and that Bcl6 and Blimp-1 antagonize each other’s function
(Johnston et al., 2009). Additionally, ICOS-dependent signals
are also important for induction of Bcl6 (Choi et al., 2011).
Thus, it is clear that many factors contribute to regulation of
Bcl6 expression and that Bcl6, in turn, regulates other T cell
transcription factors. Rather than invoking models of master
regulators in terminally differentiated cells, it may be more
accurate to think of Bcl6, T-bet, Blimp-1, and other factors as
extrinsically regulated players that dynamically regulate T cell
function.
The finding that IL-12 can generate uncommitted Tfh-Th1 cells
may have significance to human disease. For instance, in inflam-
matory bowel diseases, apparently uncommitted, IL-21+IFN-g+
cells have been found in the gut and have been suggested to
be important for intestinal tissue damage (Monteleone et al.,
2005; Sarra et al., 2010). These finding are also of interest given
the genetic link between polymorphisms of the Il21, Il2, andStat4
genes and susceptibility to human autoimmune disease (Daha
et al., 2009; Remmers et al., 2007). It is possible that alterations
to the function of STAT4 might not only affect IFN-g regulation
but could also influence Tfh cell genes.
Taken together, our findings indicate that the diverse actions
of STAT4 and T-bet underlie phenotypic heterogeneity between
Tfh and Th1 cells. These findings help to clarify seemingly
contradictory findings and argue for a coherent stepwise pro-
cess of Tfh-Th1 cell differentiation. Acting through STAT4,
IL-12 induces a transitional stage of Tfh-Th1 cells, which express
IL-21 and Bcl6. However, STAT4 also promotes T-bet expres-
sion, which along with IFN-g ultimately limits the Tfh cell pheno-
type. It is by no means inconceivable that other subsets also
share transitional stages with Tfh cells. Future studies are
needed to dissect these intriguing degrees of heterogeneity for
Tfh cell differentiation that should offer opportunities for the
treatment of autoimmune diseases.determined by FACS. The levels of expression of the indicated markers on CD45.
n = 5.
(I and J) WT or Tbx21/mice were immunized with 20 mg/mL STAg i.p. every 5 da
FACS 20 days postimmunization (I). Serum levels of STAg-specific total IgG wer
Representative data from one of two independent experiments are shown (mean
IEXPERIMENTAL PROCEDURES
Mice, Cell Isolation, and Cell Culture
C57BL/6J, Tbx21/, Ifng/, and Stat6/ mice were purchased from Jack-
son Laboratory. Stat4/ mice were provided by M. Kaplan. Stat3/ (Cd4
Cre; Stat3fl/fl) mice were generated as previously described (Wei et al.,
2007). Rag2/ and B6.SJL (CD45.1) mice were from Taconic Farms. All
mice were handled in accordance with the guidelines of the NIH Animal
Care and Use Committee. Splenic and lymph node T cells were obtained by
disrupting organs of 8- to 12-week-old mice. All cell cultures were performed
in RPMI supplemented with 10% fetal calf serum, 2 mM glutamine, 100 IU/mL
penicillin, 0.1 mg/mL streptomycin, 10 mM HEPES, 1 mM sodium pyruvate,
and 2.5 mM b-mercaptoethanol. T cells were enriched with a CD4+ T cell kit
and AutoMacs isolator (Miltenyi Biotec). Naive CD4+ T cells were isolated by
flow cytometry, staining with CD4, CD62L, CD44, and CD25 antibodies,
and were cultured in the plate-bound anti-CD3 and anti-CD28 (10 mg/mL
each) under neutral (anti-IFN-g and anti-IL-4 [10 mg/mL each]), IL-12 (IL-12
[10 ng/mL] and anti-IL-4), or IL-6 (IL-6 [20 ng/mL], anti-IFN-g, and anti-IL-4)
conditions for 3 days and then cultured further in IL-2 (50 U/mL) alone (neutral
condition) or in combination with IL-12 (IL-12 condition; Th1) or IL-6 (IL-6
condition) and grown an additional 2–5 days. Where indicated, 100 ng/mL
IFN-g, 20 ng/mL IL-21, or 10 mg/mL soluble IL-21 R/Fc chimera (R&D) was
added. Cytokines were from R&D Systems. Anti-CD3 and anti-CD28 were
from eBioscience and other antibodies were from BD Biosciences.
Intracellular Staining and Flow Cytometry
For intracellular cytokine staining, cells were restimulated for 2 hr with 50 ng/ml
PMA and 1 mg/ml ionomycin with the addition of brefeldin A (GolgiPlug;
BD), then fixed and permeabilized with Cytofix/Cytoperm solution (BD). Intra-
cellular IL-21 staining was performed with soluble IL-21 R/Fc, followed by
PE-labeled affinity-purified F(ab0 )2 fragment of goat anti-human Fcg (Jackson
ImmunoResearch Laboratories) (Suto et al., 2008), then further stained with
PerCP-Cy5.5 anti-CD4 and APC anti-IFN-g (BD). The following antibodies
were used for cell surface or intracellular staining: FITC anti-CD44, FITC
anti-Fas, PE anti-PD-1, PE anti-ICOS (BD), APC-Cy7 anti-CD4, PE-Cy7 anti-
CD45.1 (Biolegend), PerCP-Cy5.5 anti-B220, APC anti-GL7, PE anti-Bcl6,
and Alexa Fluor-647 anti-T-bet (eBioscience). CXCR5 staining was done
with biotinylated anti-CXCR5 for 1 hr, followed by APC-labeled streptavidin
(BD). Stained cells were analyzed on a flow cytometer (FACSCalibur or
FACSCanto; BD). Events were collected and analyzed with FlowJo software
(Tree Star). Analysis of expression of surface molecules and intracellular
transcription factors were evaluated in the presence and absence of PMA/ion-
omycin; however, the level of expression did not change with this short
stimulation.
DNase Hypersensitivity Mapping by DNase-seq
6–10 3 107 cells were treated with 0.01% NP-40 for 5 min to isolate 2 3 107
nuclei. Afterwards, DNaseI digestions (60–180 U/mL) were performed for
3 min at 37C. DNA fragments of 100–500 bp were isolated by sucrose
gradient centrifugation. Purified DNA was end repaired, ligated to the Illumina
single read adaptors, amplified, and further purified to the fraction of 220–
250 bp in size. The resulted libraries are sequenced with the Illumina Genome
Analyzer Iix (Illumina). Only unique reads of 36 bp were mapped to the mouse
genome (mm9) with SICER peak calling program.
ChIP-seq Analysis
ChIP-seq experiments and data processing were performed as described
previously (Wei et al., 2009, 2010). The following antibodies were used:
anti-H3K4me3 (ab8580); anti-H3K36me3 (ab9050) from Abcam; anti-T-bet
(sc-21003) from Santa Cruz Biotechnology. The genome browser views for
STAT4 binding in wild-type cells and for histone modification profiles in1-positive cells (WT) are compared to that of CD45.1-negative cells (Tbx21/).
ys for three times. Splenic GC B cells (B220+IgDloGL7hiFashi) were analyzed by
e measured by ELISA (J). n = 7 each.
± SD). *p < 0.05, **p < 0.01.
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Omnibus (GEO) database (Wei et al., 2010).
Immunoblotting
Equal amounts of total protein were electrophoresed on 4%–12%Bis-Tris gels
(Invitrogen), transferred to nitrocellulose, and blotted with the following anti-
bodies: anti-Bcl6, anti-phosho-STAT4, anti-phosho-STAT3, anti-STAT3 (Cell
Signaling), anti-T-bet, anti-STAT4 (Santa Cruz), or anti-actin (Millipore).
IRDye700- and IRDye800-labeled secondary antibodies (Rockland) were
used for detection and specific bands were visualized with an Odyssey
infrared imaging system (LI-COR Biosciences). Band intensity was quantified
and normalized to loading controls. The relative levels of Bcl6 and T-bet were
compared with each value of control conditions set as 1.0.
Quantitative Real-Time PCR
Total RNA was isolated with the use of the mirVana miRNA kit (Applied
Biosystems/Ambion); cDNA was synthesized with the Taqman reverse tran-
scription Kit (Applied Biosystems). Quantitative PCR was performed with an
ABI PRISM 7700 sequence detection system with site-specific primers and
probes (Applied Biosystems). The comparative threshold cycle method and
an internal control (b-actin) were used to normalize the expression of the target
genes. List of primers and probes from Applied Biosystems: mouse ACTB,
4352341E; Il21, Mm00517640_m1; Bcl6, Mm01342164_m1.
Retroviral Transduction
T-bet-expressing retrovirus vector (T-bet-GFP-retrovirus; T-bet-GRV) was
kindly provided by W. Strober. cDNA encoding murine Bcl6 was subcloned
into pMY-IRES-GFP retroviral vector (Cell Biolabs). All virus constructs
coexpress GFP as a selection marker for sorting. Sorted naive CD4+ T cells
from WT or Tbx21/ mice were cultured in the presence of plate-bound
anti-CD3, anti-CD28 with anti-IL-4 for 24 hr. After that, the cells were infected
with either control or T-bet- or Bcl6-expressing retrovirus and then cultured
further in IL-12 and anti-IL-4 for 3 days.
In Vivo Challenge with T. gondii
Age- and sex-matched WT and Tbx21/ mice were challenged i.p. with
20 cysts of the avirulent ME49 strain of T. gondii as preciously described (Jan-
kovic et al., 2007). For the measurement of humoral responses, mice were
immunized with 20 mg/mL STAg i.p. every 5 days for three times in total.
Splenocytes were harvested and were analyzed by FACS. Serum was also
collected and STAg-specific IgG was measured by ELISA. To assess the
T cell-intrinsic requirement for T-bet, we generated chimeric Rag2/ mice,
reconstituting with approximately five million WT (CD45.1) and approximately
five million Tbx21/ (CD45.2) naive CD4+ T cells. Transferred cells were
allowed to expand for 7 days before infection with 20 cysts of T. gondii strain
ME49 i.p., and tissues were harvested and analyzed at days 7 and 15.
Statistical Analysis
Statistical significance was determined by the Mann-Whitney U test. A p value
less than 0.05 denoted the presence of a statistically significant difference.
ACCESSION NUMBERS
The sequencing data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/geo) under the accession number
GSE33802.
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